Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
DeepWork Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
DeepWork Capital

DeepWork Capital

Operating

DeepWork Capital: An early-stage investment firm targeting high-growth companies in underserved markets.

Location
Orlando, FL, US
Founded
2015
Firm
Compare
Portfolio
Employees

Investments

Cyrano Therapeutics
Cyrano Therapeutics

Total Raised

$21.8M

Rounds

2

Series B$9MJanuary 2024
JourneyTrack
JourneyTrack

Total Raised

$3M

Rounds

3

Seed$1.5MOctober 2023
Astrocyte Pharmaceuticals
Astrocyte Pharmaceuticals

Total Raised

$31.9M

Rounds

11

Series B$6MAugust 2023
Series A$6MMay 2021
Canaery
Canaery

Total Raised

$4M

Rounds

5

SeedJuly 2023
Mobilo
Mobilo

Total Raised

$4.2M

Rounds

2

Seed$4.1MJuly 2023
Urban SDK
Urban SDK

Total Raised

$4.6M

Rounds

4

SeedJuly 2023
Seed$2.9MNovember 2021
Tauruseer
Tauruseer

Total Raised

$3.3M

Rounds

3

Seed$3MJune 2023
Intelligent Observation
Intelligent Observation

Total Raised

$2.5M

Rounds

7

SeedApril 2023
Myosin Therapeutics
Myosin Therapeutics

Total Raised

$3M

Rounds

2

SeedMarch 2023
Tsolife
Tsolife

Total Raised

$10.5M

Rounds

7

Series A$9MDecember 2022
Series UnknownJuly 2021
Kalogon
Kalogon
Seed

Total Raised

$5.2M

Rounds

3

Seed$3.3MSeptember 2022
Global Safety Management
Global Safety Management

Total Raised

$7.8M

Rounds

6

Series A$500kAugust 2022
Genascence
Genascence

Total Raised

$27.1M

Rounds

3

Series A$5MAugust 2022
Series A$10.5MJanuary 2022
Grove Biopharma
Grove Biopharma

Total Raised

$10.5M

Rounds

3

Convertible Note$2.5MJune 2022
Pre-Seed$4MJune 2021
Xendoo
Xendoo
Seed

Total Raised

$8.5M

Rounds

6

Seed$3.8MJune 2022
Aegle Therapeutics
Aegle Therapeutics
Public

Total Raised

$13.5M

Rounds

4

Convertible Note$3MApril 2022
Home Lending Pal
Home Lending Pal

Total Raised

$4.6M

Rounds

8

Undisclosed$1MMarch 2022
Lucy Labs
Lucy Labs

Total Raised

$3M

Rounds

1

Seed$3MNovember 2021
Artist Growth
Artist Growth

Total Raised

$5.3M

Rounds

3

Series UnknownOctober 2021
PikMyKid
PikMyKid

Total Raised

$1.8M

Rounds

4

Series BMay 2021